Immune to Cancer: The CRI Blog




Patient Immunotherapy Summit: Pancreatic Cancer Brief

Pancreatic cancer is one of the most difficult cancers to treat with immunotherapy and is the third-leading cause of cancer deaths in the U.S.  

Elizabeth M. Jaffee, MD, the Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and CRI Scientific Advisory Council associate director, focuses her research on pancreatic cancer. Dr. Jaffee gives a detailed overview of pancreatic cancer and its treatment landscape.

Read more:

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.